comparison of glp-1 agonists The New Weight Management Meds glp-1 drugs comparison Market Overview:

Diabetes Healthcare Professionals Consider Whole Person As diabetes healthcare professionals, we want to carefully consider which medication best matches the people in our care, considering individual values and preferences along with co-conditions including diabetes, cardiorenal metabolic co-conditions, MASH, sleep apnea and weight goals

In: StatPearls

The goal is not only to improve efficacy, but to differentiate products in a crowded and high-stakes market

Discovery of multi-receptor agonists for the GIPR and GLP-1R The multifactorial nature of physiological control of metabolism and body weight, coupled with the demonstration that gastric bypass procedures increase secretion of GLP-1 and several other gut-derived hormones, suggested that engineering medicines combining GLP-1R activity with other hormonal stimuli might offer superior clinical outcomes

The early deterioration of diabetic retinopathy observed with GLP-1 RAs may reflect rapid glucose decline that affects osmotic pressure rather than direct retinal toxicity [91]

Lancet 402 , 720730 (2023)